Recent Advances in Molecular and Genetic Research on Uveal Melanoma
Cells · 12.06.2024 · 13 (12) · 1023
DOI: 10.3390/cells13121023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.06.2024. Verfasst von Aurélie Fuentes-Rodriguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Otorhinolaryngology-Cervico-Facial Surgery, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 325 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eye Disease Foundation, Fonds de Recherche du Québec - Santé, Québec Cell, Tissue and Gene Therapy Network–ThéCell.
Abstract (Originalsprache)
Uveal melanoma (UM), a distinct subtype of melanoma, presents unique challenges in its clinical management due to its complex molecular landscape and tendency for liver metastasis. This review highlights recent advancements in understanding the molecular pathogenesis, genetic alterations, and immune microenvironment of UM, with a focus on pivotal genes, such as GNAQ/11, BAP1, and CYSLTR2, and delves into the distinctive genetic and chromosomal classifications of UM, emphasizing the role of mutations and chromosomal rearrangements in disease progression and metastatic risk. Novel diagnostic biomarkers, including circulating tumor cells, DNA and extracellular vesicles, are discussed, offering potential non-invasive approaches for early detection and monitoring. It also explores emerging prognostic markers and their implications for patient stratification and personalized treatment strategies. Therapeutic approaches, including histone deacetylase inhibitors, MAPK pathway inhibitors, and emerging trends and concepts like CAR T-cell therapy, are evaluated for their efficacy in UM treatment. This review identifies challenges in UM research, such as the limited treatment options for metastatic UM and the need for improved prognostic tools, and suggests future directions, including the discovery of novel therapeutic targets, immunotherapeutic strategies, and advanced drug delivery systems. The review concludes by emphasizing the importance of continued research and innovation in addressing the unique challenges of UM to improve patient outcomes and develop more effective treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Otorhinolaryngology-Cervico-Facial Surgery, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada.
- Hôpital du Saint-Sacrement, Regenerative Medicine Division, CHU de Québec-Université Laval Research Centre, Quebec City, QC G1S 4L8, Canada.
- Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada.
- Université Laval Cancer Research Center, Quebec City, QC G1R 3S3, Canada.
ORCID-Profile: Aurélie Fuentes-Rodriguez, Sylvain L Guérin, Solange Landreville
Förderung
- Eye Disease Foundation
- Fonds de Recherche du Québec - Santé
- Québec Cell, Tissue and Gene Therapy Network–ThéCell
- Fondation du CHU de Québec
- Vision Health Research Network
- Fonds de soutien à la recherche Joseph-Demers of Université Laval
- Fondation du CHU de Québec-Desjardins
- Centre de recherche sur le cancer de l’Université Laval
Zitieren
APA
Fuentes-Rodriguez, A., Mitchell, A., Guérin, S. L., & Landreville, S. (2024). Recent Advances in Molecular and Genetic Research on Uveal Melanoma. Cells, 13(12), 1023. https://doi.org/10.3390/cells13121023
Vancouver
Fuentes-Rodriguez A, Mitchell A, Guérin SL, Landreville S. Recent Advances in Molecular and Genetic Research on Uveal Melanoma. Cells. 2024;13(12):1023. doi:10.3390/cells13121023
BibTeX
@article{FuentesRodriguez2024,
author = {Fuentes-Rodriguez, Aurélie and Mitchell, Andrew and Guérin, Sylvain L and Landreville, Solange},
title = {Recent Advances in Molecular and Genetic Research on Uveal Melanoma},
journal = {Cells},
year = {2024},
volume = {13},
number = {12},
pages = {1023},
doi = {10.3390/cells13121023}
}
EUVIMED